Merck to Focus on Key Growth Pillars Through Spinoff of Women’s Health, Trusted Legacy Brands and Biosimilars Products into New Company (“NewCo”)
Go back to Merck to Focus on Key Growth Pillars Through Spinoff of Women’s Health, Trusted Legacy Brands and Biosimilars Products into New Company (“NewCo”)| Merck & Co. (NYSE: MRK) | Delayed: 119.62 +4.14 (3.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $115.48 | 52 Week High | $65.46 | |||
| Open | $116.53 | 52 Week Low | $47.97 | |||
| Day High | $119.63 | P/E | 81.37 | |||
| Day Low | $116.53 | EPS | $1.47 | |||
| Volume | 6,375,216 | |||||
